Inhibition of PERK-dependent pro-adaptive signaling pathway as a promising approach for cancer treatment

Journal Title: Polish Journal of Surgery - Year 2017, Vol 89, Issue 3

Abstract

Endoplasmic Reticulum (ER) is an organelle that is vital for cell growth and maintenance of homeostasis. Recent studies have reported that numerous human diseases, including cancer, are strictly connected to disruption of ER homeostasis. In order to counteract adverse intracellular conditions, cancer cells induce protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK)-dependent, pro-adaptive unfolded protein response (UPR) signaling branches. If ER stress is severe or prolonged, pro-adaptive signaling networks are insufficient, resulting in apoptotic cell death of cancer cells. The main aim: of the study was to evaluate the biological activity of a small-molecule PERK inhibitor GSK2606414 in two cancer cell lines - human neuroblastoma (SH-SY5Y) and human colorectal adenocarcinoma (HT-29) cell lines. We analyzed the level of phosphorylation of the eukaryotic initiation factor 2 (eIF2), which is the main substrate of PERK and a subsequent activator of UPR, which under long-term ER stress may evoke apoptotic death of cancer cells. Material and methods: In the study, we utilized commercially available cell lines of human colorectal adenocarcinoma HT-29 and human neuroblastoma SH-SY5Y. Cells were exposed to the tested PERK-dependent signaling inhibitor GSK2606414 in suitable culture media with addition of thapsigargin (500 nM) to induce ER stress. To identify the protein, Western blot with specific antibodies was used. Detection of immune complexes was performed using chemiluminescence. Results: We found a complete inhibition of p-eIF2α expression due to the GSK2606414 inhibitor in both cell lines, SH-SY5Y and HT-29. Conclusions: Currently available cancer treatments are insufficient and cause various side effects. It has been assumed that utilization of small-molecule inhibitors of the PERK-dependent signaling pathway, like GSK2606414, may switch the pro-adaptive branch of UPR to its pro-apoptotic branch. It is believed that the tested inhibitor GSK2606414 may become a promising treatment for many cancer types.<br/><br/>

Authors and Affiliations

Wioletta Rozpędek, Dariusz Pytel, Łukasz Dziki, Alicja Nowak, Adam Dziki, J. Alan Diehl, Ireneusz Majsterek

Keywords

Related Articles

Związek polimorfizmów XRCC6 C1310G i LIG4 T9I genów naprawy DNA szlaku NHEJ z ryzykiem występowania raka jelita grubego w populacji polskiej

WSTĘP: Rak jelita grubego (RJG) zajmuje na świecie drugie miejsce wśród przyczyn zgonów na nowotwory złośliwe. Utrata integralności genomu spowodowana jest uszkodzeniami DNA generowanymi przy użyciu czynników środowiskow...

Tuberculosis of gall-bladder mimicking malignancy – a case report

A correct preoperative diagnosis of gall-bladder tuberculosis is exceptionally unusual in the absence of pathognomic features both on clinical presentation and on imaging. Herein we present a case of 50 year female who w...

Ocena wpływu pasów brzusznych na wentylację płuc i ich zastosowanie we wczesnej fizjoterapii po dużych operacjach brzusznych – badanie prospektywne

Wczesna fizjoterapia jest ważnym elementem kompleksowego leczenia chorych po dużych operacjach brzusznych (DOB). Bezpieczne uruchamianie pacjentów wymaga stosowania odpowiednich technik pionizacji. Część fizjoterapeutów...

Gigantic Solitary Fibrous Tumour of Extra-Peritoneal Space. A Case Report and Review of the Literature

Solitary fibrous tumour (SFT) is a rare soft tissue tumour which belongs to fibroblastic/myofibroblastic group of tumours. The most often it appears in pleura, also in pericardium, internal organs, peritoneum and extrape...

Role of crossmatch testing when Luminex-SAB is negative in renal transplantation

The human leukocyte antigen (HLA) system plays an important role in the acceptance of renal graft. Long and better graft survival has been reported in patients with HLA-identical siblings and a nonreactive cytotoxicity a...

Download PDF file
  • EP ID EP189645
  • DOI 10.5604/01.3001.0010.1020
  • Views 79
  • Downloads 0

How To Cite

Wioletta Rozpędek, Dariusz Pytel, Łukasz Dziki, Alicja Nowak, Adam Dziki, J. Alan Diehl, Ireneusz Majsterek (2017). Inhibition of PERK-dependent pro-adaptive signaling pathway as a promising approach for cancer treatment. Polish Journal of Surgery, 89(3), 7-10. https://europub.co.uk./articles/-A-189645